The forebrain overgrowth mutation ( fog) was originally described as a spontaneous autosomal recessive mutation mapping to mouse chromosome 10 that produces forebrain defects, facial defects, and spina bifida. Although the fog mutant has been characterized and available to investigators for several years, the underlying mutation causing the pathology has not been known. Because of its phenotypic resemblance to apoptotic protease activating factor-1 (Apaf-1) knockout mice, we have investigated the possibility that the fog mutation is in the Apaf-1 gene. Allelic complementation, Western blot analysis, and caspase activation assays indicate that fog mutant mice lack Apaf-1 activity. Northern blot and reverse transcription-PCR analysis show that Apaf-1 mRNA is aberrantly processed, resulting in greatly reduced expression levels of normal Apaf-1 mRNA. These findings are strongly suggestive of the fog mutation being a hypomorphic Apaf-1 defect and implicate neural progenitor cell death in the pathogenesis of spina bifida-a common human congenital malformation. Because a complete deficiency in Apaf-1 usually results in perinatal lethality and fog͞fog mice more readily survive into adulthood, these mutants serve as a valuable model with which apoptotic cell death can be studied in vivo.
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spina bifida ͉ neural development ͉ apoptosis ͉ caspase ͉ cell death N eural tube closure defects account for a significant portion of the congenital malformations that affect humans (1) . Such defects include spina bifida, exencephaly, cranioschisis, and hydrocephaly. The cause and inheritance of these defects are complex, reflecting the complex developmental events required for neural tube formation and closure.
Neural plate formation, neural fold elevation, neural tube closure, and neural crest cell migration are just a few of the operations that are tightly regulated during neurulation. Many mouse models have been used to study neural tube defects (2) . The mutants studied have either arisen spontaneously or have been generated by using targeted gene disruption. One such mouse model is the forebrain overgrowth ( fog) mutant, which has a spontaneous mutation in an uncharacterized gene and is transmitted in an autosomal recessive manner (3) .
Apoptotic cell death has been shown to play a critical role in neurogenesis. Specifically, proteins required for the cytochromec-mediated apoptotic pathway [such as apoptotic protease activating factor-1 (Apaf-1), caspase-9, and caspase-3] are important for neural tube closure in vivo (4) (5) (6) (7) (8) (9) . In this biochemical cascade, cytochrome c released from the mitochondria is recruited to Apaf-1. In the presence of dATP, the cytochrome-c͞Apaf-1 complex is able to procure and promote activation of procaspase-9 to caspase-9. The activation of caspase-9 then results in the subsequent activation of caspase-3, a terminal event in apoptotic cell death. In mice, Apaf-1 deficiency results in a dramatic elevation in the number of neural progenitor cells resulting in the thickening of the neuroepithelium (9) . Because morphogenetic forces play a critical role in neurulation (10) , it is likely that the abundance of neural progenitors in Apaf-1 mutants profoundly affects the ability of the neural tube to close. Given that apoptotic cell death is crucial for appropriate neural development, uncharacterized mutant models that are used to study neurulation may possess defects in apoptotic programs. In this study, we show that mice with the fog mutation are functionally deficient in Apaf-1 protein. We find that Apaf-1 transcripts are aberrantly processed in homozygous fog mutants, resulting in reduced levels of the normal Apaf-1 message. In addition to the phenotypes that have been previously reported for the Apaf-1 knockouts generated by targeted gene disruption, the fog mutants frequently have spina bifida and some surviving adult animals have typical neural tube closure defects (3). These findings suggest that the degree of Apaf-1 expression is critical in the regulation of neural progenitor cell death, and that perturbations in this regulation result in neurodevelopmental pathology such as spina bifida.
Materials and Methods
Mapping of the Apaf-1 Allele. Polymorphisms between the Apaf-1 alleles of C57BL͞6J and SPRET mice were identified by sequencing the 3Ј end of the locus. This revealed a 10-bp allelic size difference within the 3Ј untranslated region (UTR). The following PCR primers were designed to generate a product that spans the polymorphism: Apaf-1-gap-F: 5Ј-CTATGAGCTAGTCAT-GTGTTAGA-3Ј and Apaf1-gap-R: 5Ј-CCAATTCACAGA-CACTGACA-3Ј. Genomic DNA samples derived from 94 N2 animals from the BSS backcrosses (C57BL͞6JEi ϫ SPRET͞Ei)F 1 ϫ SPRET͞Ei, or the reciprocal BSB backcrosses (C57BL͞6JEi ϫ SPRET͞Ei)F 1 ϫ C57BL͞6JEi were analyzed by PCR for the 3Ј UTR polymorphism. PCR was performed in a 20-l volume that contained 1.5 mM MgCl 2 , 50 mM KCl, 10 mM Tris (pH 9.0), 1% Triton X-100, 0.5 M each primer, 0.1 mM dNTPs, 1 unit of Taq DNA polymerase, and 25 ng of genomic DNA. After denaturation at 95°C for 1.5 min, 30 cycles of PCR were performed where each cycle consisted of 1 min at 95°C, 45 sec at 60°C, and 45 sec at 72°C. Products were then resolved on 4% NuSieve agarose (FMC) gels. The results were then compared with The Jackson Laboratory Backcross Database (available at http:͞͞www.jax.org͞resources͞ documents͞cmdata; see also http:͞͞www.informatics.jax.org͞).
Generation of Apaf-1 Knockout Mice. Mice carrying the disrupted Apaf-1 allele were generated as described (9) . Mice carrying the fog mutation were obtained from The Jackson Laboratory (stock no. 002979). Embryos possessing one disrupted Apaf-1 allele and one fog mutant allele were obtained by crossing male mice heterozygous for the fog mutation with females heterozygous for a disrupted Apaf-1 allele.
Histology. Specimens were fixed in 4% paraformaldehyde overnight and subsequently embedded in paraffin for sectioning.
Abbreviations: Apaf-1, apoptotic protease activating factor-1; RT, reverse transcription; cM, centimorgan.
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Sections were cut at 5-m increments, and stained with hematoxylin͞eosin.
Preparation of S-100 Extracts from Fibroblasts. Mouse embryonic fibroblasts derived from day 16.5 embryos were prepared and maintained by using the procedure outlined (11) . Primary fibroblast cultures were derived from the adult mouse tail. Pieces of the tissue were allowed to adhere to 25-cm 2 flasks and were incubated in Dulbecco's modified media (high glucose with glutamine) supplemented with 20% FCS and penicillin͞streptomycin. Fibroblasts were harvested and collected by centrifugation (1,800 ϫ g for 15 min at 4°C). Cell pellets were washed once with ice-cold PBS and resuspended in 5 vol of ice-cold buffer A (20 mM Hepes, pH 7.5͞10 mM KCl͞1.5 mM MgCl 2 ͞1 mM NaEDTA͞1 mM DTT͞0.1 mM PMSF). After 15 min of incubation on ice, cells were homogenized with 20 strokes of a Dounce homogenizer. After centrifugation (2,000 ϫ g, 5 min at 4°C) the supernatant was collected and centrifuged again (100,000 ϫ g, 1 h at 4°C). The resulting supernatant (S-100 extract) was stored at Ϫ80°C.
Immunoblot Analysis. Western blot analysis of Apaf-1 was performed as described (12) . Immunoblot analysis was performed by using horseradish peroxidase-conjugated goat anti-rabbit IgG and enhanced chemiluminescence (ECL) Western blotting detection reagents (Amersham Pharmacia).
In Vitro Caspase-3 Activation Assay. Procaspase-3 was translated in vitro and purified as described (13) . A 1-l aliquot of the in vitro translated procaspase-3 was incubated with 50 g of cell extract in the presence or absence of 1 mM dATP and 1 mM MgCl 2 at 30°C for 1 h. Before incubation, the volume was adjusted to 20 l with buffer A. After incubation, 7 l of 4ϫ SDS sample buffer was added, samples were then boiled for 3 min, and then subjected to SDS͞15% PAGE. The gel was transferred to a nitrocellulose filter, and 35 S-labeled protein bands were visualized on a Fuji BAS-1500 phosphorimager.
Reverse Transcription (RT)-PCR. Total RNA was purified from mouse embryonic fibroblasts by using the RNA-STAT-60 RNA isolation reagent. The total RNA was used to generate firststrand cDNA by using the SuperScript II reverse transcriptase kit and oligo(dT) primer available from Life Technologies. The first-strand cDNA was used for amplifying fragments of the Apaf-1 message. Oligonucleotides used in amplifying the aberrantly spliced Apaf-1 message from the first strand cDNA were the 1 and 13 primers, which have the sequence 5Ј-CATCAA-GACATCCTACATCATGGATCACATG-3Ј and 5Ј-GG-TACTCCACCTTCACACAGCACTG-3Ј respectively. Nearly full-length transcripts were amplified with the 1 primer and the 11 primer, 5Ј-CCGAGATTATCGACAGTCACATAGG-3Ј. The remainder of the coding region was amplified by using primers with the reverse complement sequence of 1 and 11 with the primers 5Ј-GCAATCTAGTCTCATAAGTGACCCTC-3Ј and 5Ј-GGGTCAAGCTCAGTCGAGTATAACT-3Ј, respectively. PCR used to quantify the difference in Apaf-1 message between fog mutants and wild-type animals used primer pair 1 and 14, 5Ј-TCATGAGAAGCCCAGATTTGTCTTG-3Ј. ␤-Actin message was amplified by using primers provided with the RT-PCR Primer and Control Set kit from Life Technologies.
Northern Analysis. Northern blots were performed as described (14) . Total RNA obtained from cultured fibroblasts was eluted over an oligo(dT) column (mRNA purification kit, Amersham Pharmacia), and Ϸ5 g of resulting RNA preparation was loaded per well. The blots were probed with a 32 P-labeled fragment spanning 3,600 bp of the Apaf-1 cDNA (amplified by the 1 and 11 primer pair).
Results
The similarity in phenotype between the Apaf-1 Ϫ͞Ϫ mice and fog mutant mice, as well as the proximity of both loci on mouse chromosome ten (3, 5) , suggested Apaf-1 as a candidate gene for the fog mutation. To determine the chromosomal localization at a higher resolution, Apaf-1 was mapped by using two interspecific backcross mouse DNA panels from The Jackson Laboratory (15) . Genomic DNA samples derived from 94 N 2 animals from the BSS backcrosses (C57BL͞6JEi ϫ SPRET͞Ei)F 1 ϫ SPRET͞Ei were analyzed for a clear PCR-based polymorphic marker in the 3Ј untranslated region of the Apaf-1 locus between the two species. The segregation pattern of the polymorphism was compared with The Jackson Laboratory Backcross Database, where the marker was found to cosegregate with D10Mit67 and closely segregate with several adjacent loci located on mouse chromosome 10 (Fig. 1) . The mapping places the Apaf-1 locus at consensus position 45.7 on mouse chromosome 10. Similar data, albeit of lower resolution, were obtained from the reciprocal BSB backcross panel (C57BL͞6JEi ϫ SPRET͞Ei)F 1 ϫ C57BL͞6JEi (data not shown). Previous linkage analysis has shown that the fog mutant phenotype does not recombine with either D10Mit262 [47.5 centimorgan (cM)] or D10Mit230 (49.0 cM) (3). Thus, Apaf-1 maps within the minimal region to which the fog mutation has been localized (Fig. 1) .
To further evaluate the possibility that the Apaf-1 and fog alleles represent the same gene, female mice heterozygous for a disrupted Apaf-1 allele were crossed to male mice heterozygous for the fog mutation (obtained from The Jackson Laboratory). The pups from this cross were harvested at 16.5 days of gestation (Fig. 2) . A variety of mutant phenotypes were observed, consistent with the defects reported for fog mutants (3) and with those seen in Apaf-1-deficient mice (Fig. 3) . The fog͞Apaf-1 mutant phenotype included exencephaly, cranioschesis, or either forebrain defect with lumbosacral defects. fog͞fog embryos have been reported to have similar defects in addition to lumbosacral defects alone. The relative frequency of the different phenotypes was not assessed in this experiment; the frequency of these defects has been quantified in both fog mutants and Apaf-1 knockout mice (3, 6) .
Western blot analysis of mouse embryonic fibroblasts derived from these mutant pups revealed an absence of Apaf-1 protein (Fig. 4A) . Extracts prepared from these cells also failed to activate caspase-3 in vitro, consistent with the absence of Apaf-1 ( Fig. 4B) (13) . Furthermore, fibroblasts derived from fog͞fog mutants had no detectable Apaf-1 transcript or protein by Northern (Fig. 4C Center) or Western blot analysis (Fig. 4C Left) , respectively. Because the Apaf-1 message is normally expressed at low levels, there remained a possibility that even lower levels of Apaf-1 message (undetectable by Northern analysis) were present in the fog mutant. To address this, RT-PCR was performed on total RNA from wild-type and fog͞fog mutant cultured fibroblasts. This analysis indicates that Apaf-1 transcripts are in fact present in the mutant, but are Ϸ10-to 20-fold less abundant (Fig. 4 C Right and D) . The coding region (from start codon to stop codon) of the Apaf-1 cDNA was sequenced by using fragments amplified from fog͞fog first-strand cDNA, and no mutations were found when compared with wild-type animals in the C3H͞HeJ background on which the fog mutation originated (data not shown). Southern blot analysis of genomic DNA probed with 32 P-labeled Apaf-1 cDNA revealed no differences in the gene structure of Apaf-1 between fog͞fog and C3H͞HeJ wild-type mice (data not shown). Additionally, no differences between the C3H͞HeJ background and the fog mutant allele were found in 2,700 base pairs of the promoter region or the 3Ј untranslated region (National Center for Biotechnology Information Nucleotide query, NM009684) of the Apaf-1 gene. However, one primer pair that was used to amplify the coding sequence between exons 2 and 4 of Apaf-1 (containing the first exon of its ced-4 homology domain) from fog͞fog first strand cDNA produced a predominant PCR fragment that was Ϸ1,750 bp larger than the predicted size ( Fig. 5  A and B) . The 2-kb fragment was sequenced and found to include the intron between exons 3 and 4 of the Apaf-1 gene (Fig. 5D) . Because no mutations were found at the splice acceptor or donor sites flanking exons 3 and 4 or the intron between these two exons in the fog mutants; defective Apaf-1 mRNA processing appears to be the cause of the markedly reduced Apaf-1 message, protein levels, and activity in fog mutants (Fig. 4) .
To address the possibility that a gene adjacent to Apaf-1 that regulates Apaf-1 expression was mutated in fog animals, mice carrying the fog mutation (which have a background similar to C3H͞HeJ) were outcrossed to wild-type animals carrying Apaf-1 in the BL6 background. The aberrantly sized 2-kb RT-PCR fragment was amplified from the RNA of resulting progeny, which had one Apaf-1 allele from the fog mutant and one wild-type Apaf-1 allele from the BL6 background. Two separate PCRs, differing only in the downstream primer used to amplify a 340-bp fragment located within the aberrantly sized 2-kb fragment, were then used to determine the allelic origin of the 2-kb band. A 14-bp insertion present in the third intron of Apaf-1 gene of fog animals, but not in the BL6 wild-type mice, was used in the design of the downstream primers, such that one primer included the insertion and the other did not. The insertion found in the fog animals is also found in C3H͞HeJ wild-type mice, indicating that the insertion is specific to the fog background but does not affect gene function. If the aberrant fragment resulted from a separate gene that affects Apaf-1 expression, then PCR products with primer pairs specific for the Apaf-1 gene in fog mutants and the Apaf-1 gene in BL6 wild-type mice would both be amplified. In Fig. 5C it is shown that only the primer including the insertion (specific to the Apaf-1 gene from fog mice) amplifies the 340-bp fragment located within the aberrant 2-kb band. This observation strongly suggests that the 2-kb band originates from the fog mutant allele and that the band is specific for the Apaf-1 gene rather than the result of a mutation in another gene affecting the expression of Apaf-1 in fog͞fog mice.
Discussion
Residual Apaf-1 expression likely prevents normal neural tube closure in fog͞fog mice. The fog mutation, although not yet defined on the nucleotide level, maps within the minimal region of mouse chromosome 10 containing Apaf-1, causes inefficient splicing of at least one intron in the Apaf-1 gene (the third intron) in a manner that is specific to the Apaf-1 gene in fog mutants, and results in dramatically reduced expression of Apaf-1 at the level of mRNA and protein. Furthermore, the fog mutation abolishes detectable Apaf-1 activity in vitro and is able to complement one disrupted Apaf-1 allele in producing a full Apaf-1 mutant phenotype in vivo. These results are most consistent with the fog mutation as single defect in the Apaf-1 gene and the critical neurodevelopmental role shown for Apaf-1.
Previous work has shown that modifier genes can vary the phenotype of Apaf-1-deficient mice, depending on their genetic background (9) . Thus, the phenotypic differences between the fog mutant and the Apaf-1 mutants generated by targeted disruption are likely because of differences in the activity of modifier genes between the two mutant models and the low, residual Apaf-1 expression in the fog mutants that is not seen in Apaf-1 knockouts. In Fig. 4 , fog mutants are shown to have markedly reduced levels of normal Apaf-1 message. This situation contrasts with the mutation in the Apaf-1 knockout, in which no normal message is produced. The enhanced survival of fog mutants over Apaf-1 knockout mice is best explained by the presence of residual Apaf-1 message. However, the frequent lumbosacral defects seen in fog mutants (derived in the C3H͞HeJ background) but not in Apaf-1 knockouts (derived in the 129͞BL6 background) is most likely the result of background differences. Apaf-1 mutants in a 129͞BL6 mixed background possessing both forebrain defects and lumbosacral defects have been infrequently obtained (data not shown), although such defects in Apaf-1 knockouts derived in other strains have not been reported. Specifically, Apaf-1 mutant embryos in the 129͞BL6 mixed background show exencephaly, cranioschesis, anencephaly, and lumbosacral defects in combination with exencephaly, whereas fog͞fog mutant embryos have similar defects alone as well as in combination with exencephaly or cranioschesis. The common thread in all of the reported embryonic phenotypes is the failure of appropriate neural tube closure, which has been formally demonstrated in both Apaf-1 mutants and fog͞fog mutants (3, 5, 8, 9) . Given that both adult Apaf-1-deficient males and adult fog͞fog males are infertile, the significant phenotypic overlap seen between Apaf-1 and fog͞fog mutants suggests that fog mutants have a defect in Apaf-1 expression. However, the differences in the location of the neural tube closure defects between these two animal models may indicate either that an additional mutation exists in the fog͞fog mice, which is revealed only in the presence of a particular genetic complement or reduced Apaf-1 expression, or that genetic modifiers on the background strain of the fog mutant enhance the effect of the Apaf-1 mutation on posterior neuropore closure thereby increasing the incidence of spina bifida. Based on the biochemical and genetic information presented, we conclude that the fog mutation is most likely a mutation in the Apaf-1 gene (identification of the mutation at the nucleotide level is required to make the conclusion with full certainty). The mutation affects the splicing of the third intron and the efficiency of Apaf-1 mRNA processing. Because an aberrantly sized 2-kb product was specifically amplified from the Apaf-1 gene in the fog mutant, we interpret the virtually absent expression of Apaf-1 mRNA found in fog͞fog tissues as an indicator of significant Apaf-1 transcript degradation that is the result of the reduced splicing efficiency.
A recent report has shown that decreased Apaf-1 expression, as a result of DNA methylation, contributes to the pathogenesis of malignant melanoma (16) . Here it is shown that reduced Apaf-1 expression because of aberrant Apaf-1 mRNA processing exists in fog mutant mice, which have spina bifida and survive to adulthood with neural tube closure defects. We also show that Apaf-1 deficiency can result in anencephaly. Thus, mutations affecting the expression levels of Apaf-1 or other proteins in the cytochrome-c-mediated apoptotic cascade (such as caspases-9 and -3) may play a fundamental role in the pathogenesis of spina bifida, because anencephaly and spina bifida are often present concurrently in human subjects (see Online Mendelian Inheritance in Man, Entry 182940, http://www3.ncbi.nlm.nih.gov/ Omim/). As the cytochrome-c-mediated apoptotic pathway is critical for the death of neural progenitor cells (9) , it may also be inferred that an excess of neural progenitors contributes to the pathogenesis of neural tube closure defects seen in humans.
The study of cytochrome-c-mediated apoptotic cell death in disease processes has been hampered by the embryonic lethality of the mutants deficient in any one of the proteins central to the cascade. Given that the fog mutant mice possess hypomorphic alleles of Apaf-1 and that adult mutants are readily available to investigators, examination of cell death in disease states occurring independently of the cytochrome-c-mediated cascade can be completed. Fields of investigation include (but are not limited to) immune dysfunction, ischemic cell death, and carcinogenesis.
